Blood Cancer Treatment: ABBV-319 Study

We are examining how a new intravenous treatment affects adults with relapsed or refractory diffuse large B-cell lymphoma, follicular lymphoma, or chronic lymphocytic leukemia. The study looks at potential side effects and changes in disease activity.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Assistance Publique Hopitaux De Paris
Maison Blanche, France
Centre Hospitalier Universitaire De Nantes
Clinical Hematology Department
Nantes, France
Hospices Civils De Lyon
Pavillion 1 F Marcel Berard 3e étage Service Hématologie Clinique
Oullins, France

Sponsor: AbbVie Deutschland GmbH & Co. KG
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.